News
CNTB
3.050
+7.77%
0.220
Weekly Report: what happened at CNTB last week (0406-0410)?
Weekly Report · 2d ago
Analysts Offer Insights on Healthcare Companies: Alpha Cognition Inc (ACOG), Insmed (INSM) and Connect Biopharma Holdings (CNTB)
TipRanks · 04/08 10:30
Weekly Report: what happened at CNTB last week (0330-0403)?
Weekly Report · 04/06 10:40
Weekly Buzz: SPRY Gains FDA Nod; EU Expands Kerendia Label; LLY Acquires CNTA; BIIB Snaps Up APLS
NASDAQ · 04/03 09:10
Connect Biopharma Price Target Maintained With a $10.00/Share by BTIG
Dow Jones · 04/02 04:14
Major Insider Move Signals Strong Confidence in Connect Biopharma’s Future
TipRanks · 04/02 02:02
Connect Biopharma director buys $4.0M in common stock
TipRanks · 04/01 21:15
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 04/01 21:05
Connect Biopharma director James Huang acquires $4 million common shares
Reuters · 04/01 20:31
Connect Biopharma Hldgs Q4 EPS $(0.27) Beats $(0.30) Estimate
Benzinga · 03/31 21:30
Connect Biopharma FY25 net loss widens to $55.5 million; cash, investments fall to $44 million
Reuters · 03/31 20:12
CONNECT BIOPHARMA REPORTS 2025 FULL-YEAR FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
Reuters · 03/31 20:05
Analysts Have Conflicting Sentiments on These Healthcare Companies: Sanofi (SNY), Milestone Pharmaceuticals (MIST) and Connect Biopharma Holdings (CNTB)
TipRanks · 03/31 13:50
Connect Biopharma Price Target Maintained With a $10.00/Share by BTIG
Dow Jones · 03/31 10:39
Buy Rating on CNTB Driven by Rademikibart’s Rapid Lung Function Gains, COPD Differentiation, and Strengthened Cash Runway
TipRanks · 03/31 10:36
BTIG Reiterates Buy on Connect Biopharma Hldgs, Maintains $10 Price Target
Benzinga · 03/31 10:29
Buy Rating on CNTB: Fast-Acting Rademikibart Data Underscore Differentiation and Long-Term Respiratory Opportunity
TipRanks · 03/31 10:26
BUZZ-U.S. STOCKS ON THE MOVE-Agnico Eagle Mines, ProPetro, Kezar
Reuters · 03/30 15:53
Analysts Conflicted on These Healthcare Names: Connect Biopharma Holdings (CNTB), Neumora Therapeutics, Inc. (NMRA) and Merck & Company (MRK)
TipRanks · 03/30 13:40
BUZZ-U.S. STOCKS ON THE MOVE-Insmed, United Therapeutics, CrowdStrike
Reuters · 03/30 13:12
More
Webull provides a variety of real-time CNTB stock news. You can receive the latest news about Connect Biopharma Holdings Ltd through multiple platforms. This information may help you make smarter investment decisions.
About CNTB
Connect Biopharma Holdings Limited is a global clinical-stage biopharmaceutical company. The Company is focused on advancing rademikibart, a potentially best-in-class next generation anti-interleukin-4-receptor alpha (IL-4Rα) antibody, to transform acute and chronic care in asthma and chronic obstructive pulmonary disease (COPD). Its lead product candidate, rademikibart, is an antibody designed to target interleukin-4 receptor alpha (IL-4Rα) in development for the treatment of atopic dermatitis (AD) and asthma. As an inhibitor of IL-4Rα, rademikibart blocks inflammatory signaling by both IL-4 and IL-13. The Company has completed a global Phase II trial (CBP-201-WW001) of rademikibart in adult patients with moderate-to-severe AD.